Double-blind Trial With Rikkunshito Versus Placebo on Efficacy and Safety in Patients With Functional Dyspepsia: Multi-center Study (DREAM Study)
Functional Dyspepsia
Enrolment: 128 · Results not recorded
Loading the evidence…
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Functional Dyspepsia
Enrolment: 128 · Results not recorded
Dyspepsia and Other Specified Disorders of Function of Stomach · Postprandial Distress Syndrome
Enrolment: 100 · Results not recorded
Dyspepsia
Enrolment: 34 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Bleomycin-induced acute lung injury with subsequent pulmonary fibrosis
Rikkunshito-treated mice showed higher survival, smaller reductions in body weight and food intake, and reduced neutrophil infiltration, vascular permeability, proinflammatory cytokine induction, NF-kappaB activation, alveolar epithelial cell apoptosis and subsequent fibrosis. Protection persisted…
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.